Literature DB >> 7924738

Increased permeability of macroscopically normal small bowel in Crohn's disease.

M Peeters1, Y Ghoos, B Maes, M Hiele, K Geboes, G Vantrappen, P Rutgeerts.   

Abstract

To investigate permeability alterations of the macroscopically normal jejunum in Crohn's disease, the permeation of two probes was measured during perfusion of an isolated jejunal segment. The data were compared with the results obtained by the standard per oral test in the same patients. Test probes were PEG-400 and [51Cr]EDTA. Ten normal individuals, 12 patients with Crohn's ileitis or ileocolitis, and seven patients with isolated Crohn's colitis all with normal jejunum on x-ray series were studied. Upon perfusion of the proximal small bowel, the 3-hr [51Cr]EDTA excretion was significantly increased in ileitis patients (P = 0.023) as compared to normals. The excretion exceeded the highest value of normals in eight of 12 ileitis patients. The excretion in Crohn's colitis patients was not significantly increased (P = 0.24) and abnormal excretion was found only in one of the Crohn's colitis patients. PEG-400 permeation during perfusion did not differentiate between the groups, but five of the seven patients with isolated Crohn's colitis had PEG-400 excretion exceeding the highest value in normals. Overall, 13 of the 19 patients had increased permeation of one of the two probes through jejunal mucosa during perfusion. These data suggest that the permeability is increased in the majority of patients even in segments that seem normal on x-ray.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7924738     DOI: 10.1007/bf02090367

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  Paracellular intestinal absorption of glucose, creatinine, and mannitol in normal animals: relation to body size.

Authors:  J R Pappenheimer
Journal:  Am J Physiol       Date:  1990-08

2.  Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases.

Authors:  R T Jenkins; D B Jones; R L Goodacre; S M Collins; G Coates; R H Hunt; J Bienenstock
Journal:  Am J Gastroenterol       Date:  1987-11       Impact factor: 10.864

3.  Evaluation of mannitol, lactulose and 51Cr-labelled ethylenediaminetetra-acetate as markers of intestinal permeability in man.

Authors:  M Elia; R Behrens; C Northrop; P Wraight; G Neale
Journal:  Clin Sci (Lond)       Date:  1987-08       Impact factor: 6.124

4.  Intestinal permeability in patients with Crohn's disease and their first degree relatives.

Authors:  K Teahon; P Smethurst; A J Levi; I S Menzies; I Bjarnason
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

5.  Studies of intestinal permeability in inflammatory diseases using polyethylene glycol 400.

Authors:  R T Jenkins; R L Goodacre; P J Rooney; J Bienenstock; T Sivakumaran; W H Walker
Journal:  Clin Biochem       Date:  1986-10       Impact factor: 3.281

6.  Small intestinal permeability to mannitol, lactulose, and polyethylene glycol 400 in celiac disease.

Authors:  S O Ukabam; B T Cooper
Journal:  Dig Dis Sci       Date:  1984-09       Impact factor: 3.199

7.  PEG 400, a hydrophilic molecular probe for measuring intestinal permeability.

Authors:  T Y Ma; D Hollander; P Krugliak; K Katz
Journal:  Gastroenterology       Date:  1990-01       Impact factor: 22.682

8.  Alteration of intestinal tight junction structure and permeability by cytoskeletal contraction.

Authors:  J L Madara; R Moore; S Carlson
Journal:  Am J Physiol       Date:  1987-12

9.  Cr-ethylenediaminetetraacetic acid absorption test. Methodologic aspects.

Authors:  L Aabakken
Journal:  Scand J Gastroenterol       Date:  1989-04       Impact factor: 2.423

10.  Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor.

Authors:  D Hollander; C M Vadheim; E Brettholz; G M Petersen; T Delahunty; J I Rotter
Journal:  Ann Intern Med       Date:  1986-12       Impact factor: 25.391

View more
  21 in total

Review 1.  The immunopathogenesis of Crohn's disease: a three-stage model.

Authors:  Gavin W Sewell; Daniel Jb Marks; Anthony W Segal
Journal:  Curr Opin Immunol       Date:  2009-08-08       Impact factor: 7.486

2.  Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence?

Authors:  J D Söderholm; G Olaison; E Lindberg; U Hannestad; A Vindels; C Tysk; G Järnerot; R Sjödahl
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

Review 3.  The intestinal epithelial barrier: a therapeutic target?

Authors:  Matthew A Odenwald; Jerrold R Turner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-16       Impact factor: 46.802

Review 4.  Familial aggregation in inflammatory bowel disease: is it genes or environment?

Authors:  Tiago Nunes; Gionata Fiorino; Silvio Danese; Miquel Sans
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

Review 5.  Replication and meta-analysis of 13,000 cases defines the risk for interleukin-23 receptor and autophagy-related 16-like 1 variants in Crohn's disease.

Authors:  Lynn Cotterill; Debbie Payne; Scott Levinson; John McLaughlin; Emma Wesley; Mark Feeney; Hilary Durbin; Simon Lal; Alistair Makin; Simon Campbell; Stephen A Roberts; Catherine O'Neill; Cathryn Edwards; William G Newman
Journal:  Can J Gastroenterol       Date:  2010-05       Impact factor: 3.522

6.  Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn's disease: a randomized controlled trial.

Authors:  Jaya Benjamin; Govind Makharia; Vineet Ahuja; K D Anand Rajan; Mani Kalaivani; Siddhartha Datta Gupta; Yogendra Kumar Joshi
Journal:  Dig Dis Sci       Date:  2011-10-26       Impact factor: 3.199

7.  Absorption profiles for polyethylene glycols after regional jejunal perfusion and oral load in healthy humans.

Authors:  J D Söderholm; G Olaison; A Kald; C Tagesson; R Sjödahl
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

8.  Adrenoceptor-mediated modulation of Evans blue dye permeation of rat small intestine.

Authors:  S Lange; D S Delbro
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

9.  Validating biomarkers of treatable mechanisms in irritable bowel syndrome.

Authors:  M Camilleri; A Shin; I Busciglio; P Carlson; A Acosta; A E Bharucha; D Burton; J Lamsam; A Lueke; L J Donato; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2014-09-22       Impact factor: 3.598

10.  Intestinal permeability and its association with the patient and disease characteristics in Crohn's disease.

Authors:  Jaya Benjamin; Govind K Makharia; Vineet Ahuja; Mani Kalaivani; Yogendra K Joshi
Journal:  World J Gastroenterol       Date:  2008-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.